Evaluation of the expression of matrix metalloproteinase type 9 in cervicovaginal smears: a cytlogical study (2011)
- Authors:
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Assunto: METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 47, suppl. 1, p. 18 res. FCF031, 2011
- Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo
-
ABNT
MATHEUS, Erika Regina et al. Evaluation of the expression of matrix metalloproteinase type 9 in cervicovaginal smears: a cytlogical study. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jan. 2026. , 2011 -
APA
Matheus, E. R., Zonta, M. A., Paruci, P., Cardeal, L. B. da S., Velame, F., Pignatari, A. C. C., & Maria-Engler, S. S. (2011). Evaluation of the expression of matrix metalloproteinase type 9 in cervicovaginal smears: a cytlogical study. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Matheus ER, Zonta MA, Paruci P, Cardeal LB da S, Velame F, Pignatari ACC, Maria-Engler SS. Evaluation of the expression of matrix metalloproteinase type 9 in cervicovaginal smears: a cytlogical study. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 18 res. FCF031.[citado 2026 jan. 12 ] -
Vancouver
Matheus ER, Zonta MA, Paruci P, Cardeal LB da S, Velame F, Pignatari ACC, Maria-Engler SS. Evaluation of the expression of matrix metalloproteinase type 9 in cervicovaginal smears: a cytlogical study. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 18 res. FCF031.[citado 2026 jan. 12 ] - Processo invasor do câncer cervical uterino: análise das metaloproteinases -2, -9, -14, TIMP-2 e do gene supressor de tumor RECK
- Organotypic models in drug development
- RECK is required for migration and invasiveness in melanoma after vemurafenib treatment
- Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma
- Novel kojic acid derivatives ACT on melanogenesis and skin age-related enzymes
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma
- Evaluation of antimetastatic activity in vemurafenib resistant melanoma cell lines after DM-1 treatment
- The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies
- Apoptosis expression in vemurafenib-resistant melanoma cells induced by curcumin analog DM-1
- RECK-tumor suppressor gene is overexpressed in vermurafenib-resistant human melanoma cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
